Annual sales fell from KRW 256.5 billion in 2022 to KRW 212.7 billion in 2023 (down 17.1%), KRW 173.2 billion in 2024 (down 18.6%) and KRW 136.3 billion in 2025 (down 21.3%), a three-year decline from 2023 through 2025. Sales were largest in 2022 and smallest in 2025 within the 2022 to 2025 period.
Operating losses widened from KRW 1.52 billion in 2022 to KRW 14.4 billion in 2023, then narrowed to KRW 8.94 billion in 2024 and KRW 1.97 billion in 2025. The company has posted operating losses for four consecutive years from 2022 to 2025.
Operating margin was -0.6% in 2022, -6.8% in 2023, -5.2% in 2024 and -1.4% in 2025. Net losses attributable to controlling shareholders were KRW 1.61 billion in 2022, KRW 22.9 billion in 2023, KRW 21.7 billion in 2024 and KRW 10.6 billion in 2025.
In 2023 and 2024 the net loss was far larger than the operating loss, which points to a heavy burden from non-operating items. Restructuring ran alongside this period.
The company sold a China-based LCD-related unit in 2024 and later decided to halt part of the injection business at a US subsidiary, exiting lower-margin activities. Operating cash flow moved from negative KRW 4.81 billion in 2022 to KRW 3.87 billion in 2023, KRW 884 million in 2024 and KRW 11.7 billion in 2025.
On a quarterly basis, Q3 2025 showed revenue of KRW 36.4 billion, operating profit of KRW 933 million and controlling-shareholder net income of KRW 2.71 billion.
Q4 2025 revenue fell 20.6% quarter on quarter to KRW 28.9 billion, with an operating loss of KRW 818 million and a controlling-shareholder net loss of KRW 2.47 billion.
Q1 2026 revenue rose 24.1% quarter on quarter to KRW 35.9 billion, with operating profit of KRW 679 million and controlling-shareholder net income of KRW 3.85 billion. Q2 2026 revenue was KRW 40.4 billion, operating profit KRW 1.37 billion and a controlling-shareholder net loss of KRW 667 million.
Q3 2026 revenue reached KRW 42.9 billion, up 17.8% year on year, while operating profit was KRW 905 million, down 3.0% year on year, and the controlling-shareholder net loss widened to KRW 7.1 billion.
The company attributed the Q1 2026 gross margin rise from 3.6% to 11.5% and a 22.4% year-on-year drop in SG&A to cost improvements and production efficiency.